Andrea Haitel

Vienna General Hospital — Austria

Medicine · Health Sciences

51h-index8.5kcitations233works4.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Bladder and Urothelial Cancer Treatments(110), Urinary and Genital Oncology Studies(69), Renal cell carcinoma treatment(55), Renal and related cancers(29), Prostate Cancer Treatment and Research(24)

Publications233 total

Towards Defining Follow-up Strategies for Patients with Primary Intermediate-risk Non–muscle-invasive Bladder Cancer
European Urology Oncology·2025· 4 citedOpen Access
Second TURB, restaging TURB or repeat TURB in primary T1 non-muscle invasive bladder cancer: impact on prognosis?
International Urology and Nephrology·2023· 11 citedOpen Access
Erratum to “European Association of Urology (EAU) Prognostic Factor Risk Groups for Non–muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel” [Eur. Urol. 79(4) (2021) 480–488]
European Urology·2023· 4 cited
Prognosis of Primary Papillary Ta Grade 3 Bladder Cancer in the Non–muscle-invasive Spectrum
European Urology Oncology·2023· 23 citedOpen Access
Corrigendum to < Caveolin-1 as prognostic factor of disease recurrence and survival in patients treated with radical cystectomy for bladder cancer>, urologic oncology: Seminars and original investigations volume 35, issue 6, June 2017, pages 356-362
Urologic Oncology Seminars and Original Investigations·2022
T1G1 Bladder Cancer: Prognosis for this Rare Pathological Diagnosis Within the Non–muscle-invasive Bladder Cancer Spectrum
European Urology Focus·2022· 6 cited
Molecular and Pharmacological Bladder Cancer Therapy Screening: Discovery of Clofarabine as a Highly Active Compound
European Urology·2022· 26 citedOpen Access
Comparison of Permethrin-Based Treatment Strategies against Scabies in Infants and Young Children
The Journal of Pediatrics·2022· 11 citedOpen Access
More than ancillary records: clinical implications of renal pathology examination in tumor nephrectomy specimens
Journal of Nephrology·2021· 9 citedOpen Access
Prognostic Value of the WHO1973 and WHO2004/2016 Classification Systems for Grade in Primary Ta/T1 Non–muscle-invasive Bladder Cancer: A Multicenter European Association of Urology Non–muscle-invasive Bladder Cancer Guidelines Panel Study
European Urology Oncology·2021· 98 cited
European Association of Urology (EAU) Prognostic Factor Risk Groups for Non–muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel
European Urology·2021· 417 cited
Visibility of significant prostate cancer on multiparametric magnetic resonance imaging (MRI)—do we still need contrast media?
European Radiology·2020· 20 citedOpen Access
Thyroid and androgen receptor signaling are antagonized by μ‐Crystallin in prostate cancer
International Journal of Cancer·2020· 25 citedOpen Access
Discovery of Molecular DNA Methylation-Based Biomarkers through Genome-Wide Analysis of Response Patterns to BCG for Bladder Cancer
Cells·2020· 20 citedOpen Access
DNA damage repair gene alteration status as a predictive marker for response to neoadjuvant chemotherapy in muscle invasive bladder cancer
European Urology Open Science·2020Open Access
The clinical value of the urokinase-plasminogen activator system (uPA) in patients with radical cystectomy (RC) for bladder cancer
European Urology Open Science·2020Open Access
The expression of urokinase-type plasminogen activator system in upper tract urothelial carcinoma and its prognostic value after radical nephroureterectomy
Urologic Oncology Seminars and Original Investigations·2020· 2 cited
<i> <scp>STAT</scp> 3 </i> ‐dependent analysis reveals <i> <scp>PDK</scp> 4 </i> as independent predictor of recurrence in prostate cancer
Molecular Systems Biology·2020· 88 citedOpen Access
The prognostic value of the urokinase-plasminogen activator system (uPA) in bladder cancer patients treated with radical cystectomy (RC)
Urologic Oncology Seminars and Original Investigations·2020· 7 cited
The prognostic impact of tumour NSD2 expression in advanced prostate cancer
Biomarkers·2020· 11 cited
page 1 of 12Next →

Frequent Co-authors

Michael Marberger(21), Shahrokh F. Shariat(12), Mesut Remzi(12), Martin Susani(8), Tobias Klatte(8), Matthias Waldert(7), Michela de Martino(7), Richard Zigeuner(6), Christine Mian(6), Vitaly Margulis(6), Karim Bensalah(6), Jay D. Raman(6), Georg Schatzl(5), Armin Pycha(5), Alon Z. Weizer(5), Christopher G. Wood(5), Morgan Rouprêt(4), Gero Kramer(4), Michele Lodde(4), Peter Mazal(4)